| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69acaefdafb0c568e4a8788890c3de74 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 |
| filingDate |
1992-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_681048fb540aaa384a0ce7ad17fad984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cd0fca77d795b6f244bd1ec5926baf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25fa1ee497b4d020f1bbba1fe79cba1c |
| publicationDate |
1994-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0599977-A1 |
| titleOfInvention |
Hiv-treatment method with low-toxicity amphotericin b |
| abstract |
A method of inhibiting HIV infection in peripheral blood macrophages as demonstrated by inhibition of HIV p24 antigen expression in infected cells. In this method, infected macrophages are exposed to a composition comprising particles of amphotericin B: cholesteryl sulphate having a molar ratio of between 1:0.5 and 1:4, at a concentration equal to at least about 0, 01 muM of amphotericin B. |
| priorityDate |
1991-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |